Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Globo H-KLH (OPT-822/821) in Non-Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02132988Phase 2Unknown
- Sponsor
- Mackay Memorial Hospital
- Start
- Nov 2013
- Primary completion
- Nov 2017
- Modality
- Therapeutic Vaccines, Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of adagloxad simolenin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Mackay Memorial Hospital. Status: unknown.
02
Drugs
adagloxad simolenin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02132988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132988.